Monocytes/Macrophages and Atherogenesis

Sergey Kozlov1, Tatiana Riazantseva1, Ivan Melnikov1,2

  • 1National Medical Research Centre of Cardiology Named After Academician E.I. Chazov of the Ministry of Health of the Russian Federation, 15A 3-rd Cherepkovskaya Street, Moscow 121552, Russia.

Insights

Monocytes/macrophages are key players in atherosclerosis, driving inflammation and plaque growth, but also aiding in lesion resolution. Understanding their dual role is crucial for developing new cardiovascular disease treatments.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Atherosclerosis is a major cardiovascular disease driven by lipoprotein retention and vascular inflammation.
  • Monocytes/macrophages are central to atherogenesis, influencing inflammation, plaque development, and stability.
  • Their complex, dual role necessitates further research for therapeutic strategies.

Purpose of the Study:

  • To review current data on monocyte/macrophage classification and functions in atherosclerosis.
  • To discuss hypotheses on monocyte/macrophage involvement in atherogenesis.
  • To identify existing gaps in knowledge regarding these cells in cardiovascular disease.

Main Methods:

  • Literature review of current research on monocytes/macrophages in atherogenesis.
  • Synthesis of data on cell classification, functions, and disease involvement.
  • Identification of research gaps and future directions.

Main Results:

  • Monocytes/macrophages are pivotal in initiating and escalating vascular inflammation.
  • These cells significantly contribute to atherosclerotic plaque growth and destabilization.
  • Conversely, monocytes/macrophages are also vital for resolving inflammation and stabilizing lesions.

Conclusions:

  • Monocyte/macrophage function is critical in both the progression and resolution phases of atherosclerosis.
  • Further research into their complex roles is essential for novel therapeutic interventions.
  • Targeting monocyte/macrophage pathways may offer new strategies for preventing atherosclerosis and its complications.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301